Enzon Pharmaceuticals, Inc. (ENZN) Reports Q4 Loss of $0.10
Tweet
Share
E-mailGet Alerts ENZN Hot Sheet
Price: $4.35 --0%
Financial Fact:
Diluted (in Dollars per share): -0.1
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Diluted (in Dollars per share): -0.1
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q4 EPS of ($0.10), versus ($0.16) reported last year. Revenue from royalties for the quarter came in at $9.8 million, versus $10.6 million reported last year.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)
- Cintas beats estimates but stock edges lower
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
